Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 132.04 USD | -2.38% |
|
-8.84% | +51.18% |
| Market Cap | 8.62B 7.73B 7.06B 6.45B 12.15B 810B 12.53B 85.15B 33.95B 432B 32.35B 31.65B 1,365B | P/E 2026 * |
27.1x | P/E 2027 * | 1,320x |
|---|---|---|---|---|---|
| Enterprise Value | 8.09B 7.26B 6.63B 6.05B 11.41B 761B 11.77B 79.94B 31.88B 406B 30.37B 29.72B 1,281B | EV / Sales 2026 * |
14.1x | EV / Sales 2027 * | 35.4x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -2.38% | ||
| 1 week | -8.84% | ||
| Current month | -8.84% | ||
| 1 month | -6.30% | ||
| 3 months | -9.48% | ||
| 6 months | +33.58% | ||
| Current year | +51.18% |
| 1 week | 128 |  | 146 |
| 1 month | 126.39 | | 152.18 |
| Current year | 77 | | 160.81 |
| 1 year | 77 | | 160.81 |
| 3 years | 14.78 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Financial Officer | 175,887 | 0.2718% | ||
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.38% | -8.84% | +66.00% | +701.70% | 8.62B | |
| -4.83% | +3.51% | +55.00% | +63.79% | 66.7B | |
| +0.02% | +1.07% | +11.72% | +75.63% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +100.18% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +105.85% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +35.86% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +794.74% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +55.48% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +73.49% | 33.29B | |
| +5.19% | +1.62% | -39.69% | +368.87% | 25.1B | |
| Average | +0.78% | +1.50% | +50.87% | +237.56% | 41.53B | |
| Weighted average by Cap. | +0.59% | +2.83% | +50.24% | +176.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 572M 513M 469M 428M 806M 53.77B 832M 5.65B 2.25B 28.69B 2.15B 2.1B 90.57B | 229M 206M 188M 172M 323M 21.56B 334M 2.27B 904M 11.51B 861M 843M 36.32B |
| Net income | 346M 311M 284M 259M 488M 32.57B 504M 3.42B 1.37B 17.38B 1.3B 1.27B 54.86B | 46.25M 41.48M 37.91M 34.61M 65.2M 4.35B 67.26M 457M 182M 2.32B 174M 170M 7.32B |
| Net Debt | -527M -473M -432M -394M -743M -49.53B -766M -5.21B -2.08B -26.43B -1.98B -1.94B -83.43B | -494M -443M -405M -370M -697M -46.46B -719M -4.88B -1.95B -24.79B -1.86B -1.82B -78.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | US$132.04 | -2.38% | 972,945 |
| 05/11/26 | US$135.26 | -5.66% | 584,678 |
| 04/11/26 | US$143.37 | +2.23% | 777,232 |
| 03/11/26 | US$140.24 | +0.62% | 674,722 |
| 02/11/26 | US$139.37 | -3.78% | 486,660 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
